Dr. Vildan Kayku - Neolife Tıp Merkezi

+90 212 385 31 00

Uluslararası Hasta

PACS

Online Sonuç

Online Randevu

Medical Oncology Specialist

Dr. Vildan Kayku

Areas of Interest

Breast cancer
Lung cancer
Colorectal cancer
Prostate cancer
Skin cancer
Gastric (stomach) cancer
Liver cancer
Cervical (uterine) cancer
Kidney cancer
Pancreatic cancer
Esophageal cancer

Education

2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology

2009 – 2013
Ufuk University Faculty of Medicine, Department of Internal Medicine

1999 – 2006
Eskişehir Osmangazi University Faculty of Medicine

Work Experience

2024

Neolife Medical Center

2024

Kolan Beylikdüzü Hospital

2023 – 2024

Memorial Bahçelievler Hospital

2020 – 2023

Acıbadem Maslak Hospital

2019 – 2020

Istanbul Aydın University VM Medical Park Florya Hospital

2017 – 2019

Republic of Turkey, University of Health Sciences, Van Training and Research Hospital

2014 – 2017

Hacettepe University Oncology Institute, Department of Medical Oncology

2013 – 2014

Kars State Hospital

2009 – 2013

Ufuk University Dr. Rıdvan Ege Hospital, Department of Internal Medicine

2007 – 2009

Hacettepe University Faculty of Medicine, Department of Physiology

Professional Trainings

Participation in Turkish Medical Oncology Congresses, National Cancer Congresses, and National Immunotherapy & Oncology Congresses
Courses organized by the Turkish Society of Medical Oncology

Memberships

Turkish Society of Medical Oncology
Istanbul Medical Chamber

Scientific Contributions

- - 6 scientific articles published in national and international journals
  - 21 papers presented at national congresses
  - 3 papers presented at international congresses
  - 1 book chapter translation:
    Atlas of Internal Medicine, 3rd Edition – Chapter 12: Hepatology (Turkish Translation)
  - 3 authored book chapters:
    1. Immunotherapy in Oncology – Immunotherapy in Small Cell Lung Cancer, Chapter 13, 2020
    2. Endocrine System Tumors – The Role of Immunotherapy in Neuroendocrine Tumors, Chapter 41, 2021
    3. Antineoplastic Drugs – Mechanisms of Action and Classification of Antimetabolites, Chapter 14, 2022
  - 1 oral presentation at a national congress:
    Chemotherapy in Cervical Cancer, 3rd National Urogenital Cancers Congress, 2019
  3 papers presented at international congresses

Neolife’ın hasta odaklı yaklaşımı ve kalitesi Avrupa’da açtığımız 6 yeni merkezle yurtdışında da onkoloji konusunda güvenilen bir isim olmasını sağlamıştır.

Kurumsal

Tedavi

İletişim